Mirtazapine: Difference between revisions

>Theacidman
m Mirtazapine is not an inverse agonist. An inverse agonist reverses site activity, and antagonists block the site from being activated.
>Jkadosh15
m Added its relation to other substances in its class when having the potential to cause RLS
Line 18: Line 18:


==Pharmacology==
==Pharmacology==
Mirtazapine acts as an [[antagonist]] upon the following receptors:<ref name="Fernandez2005">{{cite journal | vauthors=((Fernández, J.)), ((Alonso, J. M.)), ((Andrés, J. I.)), ((Cid, J. M.)), ((Díaz, A.)), ((Iturrino, L.)), ((Gil, P.)), ((Megens, A.)), ((Sipido, V. K.)), ((Trabanco, A. A.)) | journal=Journal of Medicinal Chemistry | title=Discovery of New Tetracyclic Tetrahydrofuran Derivatives as Potential Broad-Spectrum Psychotropic Agents | volume=48 | issue=6 | pages=1709–1712 | date=1 March 2005 | url=https://pubs.acs.org/doi/10.1021/jm049632c | issn=0022-2623 | doi=10.1021/jm049632c}}</ref><ref>{{cite journal | vauthors=((Boer, Th. de)), ((Maura, G.)), ((Raiteri, M.)), ((Vos, C. J. de)), ((Wieringa, J.)), ((Pinder, R. M.)) | journal=Neuropharmacology | title=Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, org 3770 and its enantiomers | volume=27 | issue=4 | pages=399–408 | date=1 April 1988 | url=https://www.sciencedirect.com/science/article/pii/0028390888901499 | issn=0028-3908 | doi=10.1016/0028-3908(88)90149-9}}</ref>
Mirtazapine acts as an [[antagonist]]/inverse agonist upon the following receptors:<ref name="Fernandez2005">{{cite journal | vauthors=((Fernández, J.)), ((Alonso, J. M.)), ((Andrés, J. I.)), ((Cid, J. M.)), ((Díaz, A.)), ((Iturrino, L.)), ((Gil, P.)), ((Megens, A.)), ((Sipido, V. K.)), ((Trabanco, A. A.)) | journal=Journal of Medicinal Chemistry | title=Discovery of New Tetracyclic Tetrahydrofuran Derivatives as Potential Broad-Spectrum Psychotropic Agents | volume=48 | issue=6 | pages=1709–1712 | date=1 March 2005 | url=https://pubs.acs.org/doi/10.1021/jm049632c | issn=0022-2623 | doi=10.1021/jm049632c}}</ref><ref>{{cite journal | vauthors=((Boer, Th. de)), ((Maura, G.)), ((Raiteri, M.)), ((Vos, C. J. de)), ((Wieringa, J.)), ((Pinder, R. M.)) | journal=Neuropharmacology | title=Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, org 3770 and its enantiomers | volume=27 | issue=4 | pages=399–408 | date=1 April 1988 | url=https://www.sciencedirect.com/science/article/pii/0028390888901499 | issn=0028-3908 | doi=10.1016/0028-3908(88)90149-9}}</ref>


*[[serotonin|5-HT<sub>2A</sub> receptor]]<ref name="Fernandez2005" />
*[[serotonin|5-HT<sub>2A</sub> receptor]]<ref name="Fernandez2005" />
Line 50: Line 50:


{{Preamble/SubjectiveEffects}}
{{Preamble/SubjectiveEffects}}
{{effects/base
{{effects/base
|{{effects/physical|
|{{effects/physical|
Line 63: Line 64:
*'''[[Effect::Bronchodilation]]''' - This can cause swallowing to be extremely difficult and uncomfortable, as with some other [[deliriants|anticholinergics]] such as [[diphenhydramine]]. As with [[diphenhydramine]], it is most prominent during the onset phase of the experience and often fades away as the peak sets in.
*'''[[Effect::Bronchodilation]]''' - This can cause swallowing to be extremely difficult and uncomfortable, as with some other [[deliriants|anticholinergics]] such as [[diphenhydramine]]. As with [[diphenhydramine]], it is most prominent during the onset phase of the experience and often fades away as the peak sets in.
*'''[[Effect::Muscle relaxation]]'''
*'''[[Effect::Muscle relaxation]]'''
*'''[[Effect::Restless legs]]''' - This effect is considered slightly less apparent than it is with [[diphenhydramine]].
*'''[[Effect::Restless legs]]''' - This effect is considered slightly less apparent than it is with [[diphenhydramine]] but more apparent than other atypical antidepressants like Trazadone or Doxepin.
*'''[[Effect::Nausea suppression]]'''
*'''[[Effect::Nausea suppression]]'''
}}
}}